Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SeegnalFRA:2I1 -0.28%2 Days Payable is 137.98 as of Mar. 2026, which is 13% below its 10-year median of 158.61. GuruFocus rates FRA:2I1 with a GF Score™ of 2/100. The stock has 3 warning signs investors should review. Among 605 Healthcare Providers & Services companies, Seegnal ranks better than 79.17% on this metric.
Seegnal's average Accounts Payable for the
three
months ended in Mar. 2026 was €0.56 Mil. Seegnal's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €0.37 Mil.
Hence, Seegnal's Days Payable for the
three
months ended in Mar. 2026 was 137.98.
The historical rank and industry rank for Seegnal's Days Payable or its related term are showing as below:
FRA:2I1'
s Days Payable Range Over the Past 10 Years
Min: 143.54 Med: 158.61 Max: 160.57
Current: 143.54
During the past 2 years, Seegnal's highest Days Payable was 160.57. The lowest was 143.54. And the median was 158.61.
FRA:2I1's Days Payable is ranked better than 79.17% of 605
companies
in the Healthcare Providers & Services industry
Industry Median: 57.08
vs FRA:2I1: 143.54
Seegnal's Days Payable
declined
from Mar. 2025 (166.23) to Mar. 2026 (137.98).
It may suggest that Seegnalaccelerated paying its suppliers.
The historical data trend for Seegnal's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:2I1 vs VEEV, BTSG, HQY: Days Payable Comparison
For the Health Information Services subindustry, Seegnal's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Seegnal Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Seegnal's Days Payable distribution charts can be found below:
* The bar in red indicates where Seegnal's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Seegnal's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Seegnal (FRA:2I1) has a Days Payable of 137.98 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Seegnal and its competitors. This is 13% below median its historical median of 158.61. Over the past decade, Seegnal's Days Payable has ranged from 143.54 to 160.57. According to the industry distribution chart, Seegnal ranks #126 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 20.8%.
Is Seegnal's Days Payable too high?
Seegnal's current Days Payable of 137.98 is 13% below median its 10-year median of 158.61. Over the past 10 years, this metric has ranged from a low of 143.54 to a high of 160.57. The Healthcare Providers & Services industry median Days Payable is 57.08. Seegnal's value of 137.98 is 141.7% above this industry median. Based on the distribution chart, Seegnal ranks #126 out of 605 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Seegnal has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does Seegnal's Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Seegnal ranks #126 out of 605 companies for Days Payable. This places Seegnal in the top 21% of its industry — outperforming the majority of peers. The industry median Days Payable is 57.08. Seegnal's value of 137.98 is 141.7% above this benchmark. Historically, Seegnal's own Days Payable has ranged from 143.54 to 160.57 over the past decade. While the company's 10-year median is 158.61 vs. the industry median of 57.08, Seegnal has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.08, based on 605 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Seegnal's current Days Payable of 137.98 is 141.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Seegnal and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Seegnal's current Days Payable is 137.98, which is 13% below median its own 10-year median of 158.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seegnal stock overvalued right now?
Seegnal (FRA:2I1) has a current Days Payable of 137.98. The current Days Payable is 137.98, which is 13% below median its 10-year median of 158.61 and 141.7% above the Healthcare Providers & Services industry median of 57.08. Seegnal's overall GF Score™ is 2/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Seegnal (FRA:2I1), the current Days Payable is 137.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Seegnal Inc is a med-tech software as a service (SaaS) company focused on the development and commercialization of a patient-centric clinical decision support system designed to mitigate drug-related problems at the point of care. It provides AI-enhanced clinical decision support software that helps healthcare providers prescribe medications safely and efficiently at the point of care (the Seegnal Platform). It analyzes patient-specific clinical data and medication regimens in real time to identify potential drug-related risks, including drug-drug interactions, contraindications, and adverse drug events. By integrating with electronic medical record systems, its platform supports clinicians in improving patient safety, optimizing medication use, and reducing healthcare costs.
2GF Score
Get the complete analysis for FRA:2I1
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2I1 has been successfully added to your 
